Villiers C L, Chesne S, Lacroix M B, Arlaud G J, Colomb M G
Biochem J. 1982 Apr 1;203(1):185-91. doi: 10.1042/bj2030185.
Lactoperoxidase-catalysed surface iodination and sucrose-gradient ultracentrifugation were used to investigate the structure of human complement component C1. 1. Proenzymic subcomponents C1r and C1s associated to form a trimeric C1r2-C1s complex (7.6 S) in the presence of EDTA, and a tetrameric Clr2-C1s2 complex (9.1 S) in the presence of Ca2+. Iodination of the 9.1 S complex led to a predominant labelling of C1r (70%) over C1s (30%), essentially located in the b-chain moiety of C1r and in the a-chain moiety of C1s. 2. Reconstruction of proenzymic soluble C1 (15.2 S) from C1q, C1r and C1s was partially inhibited when C1s labelled in its monomeric form was used and almost abolished when iodinated C1r was used. Reconstruction of fully activated C1 was not possible, whereas hybrid C1q-C1r2-C1s2 complex was obtained. 3. Iodination of proenzymic or activated C1 bound to IgG-ovalbumin aggregates led to an equal distribution of the radioactivity between C1q and C1r2-C1s2. With regard to C1q, the label distribution between the three chains was similar whether C1 was in its proenzymic or activated form. Label distribution in the C1r2-C1s2 moiety of C1 was the same as that obtained for isolated C1r2-C1s2, and this was also true for the corresponding activated components. However, two different labelling patterns were found, corresponding to the proenzyme and the activated states.
运用乳过氧化物酶催化的表面碘化和蔗糖密度梯度超速离心法研究人补体成分C1的结构。1. 在存在乙二胺四乙酸(EDTA)的情况下,酶原亚成分C1r和C1s缔合形成三聚体C1r2 - C1s复合物(7.6 S),而在存在钙离子(Ca2+)的情况下形成四聚体Clr2 - C1s2复合物(9.1 S)。对9.1 S复合物进行碘化时,C1r的标记占主导(70%),而C1s的标记为30%,主要位于C1r的b链部分和C1s的a链部分。2. 当使用以单体形式标记的C1s时,从C1q、C1r和C1s重建酶原可溶性C1(15.2 S)受到部分抑制,而当使用碘化的C1r时,重建几乎完全被抑制。无法重建完全活化的C1,然而获得了杂交的C1q - C1r2 - C1s2复合物。3. 对结合到免疫球蛋白G - 卵清蛋白聚集体上的酶原或活化C1进行碘化,导致放射性在C1q和C1r2 - C1s2之间均匀分布。就C1q而言,无论C1处于酶原形式还是活化形式,三条链之间的标记分布相似。C1的C1r2 - C1s2部分的标记分布与分离的C1r2 - C1s2相同,相应的活化成分也是如此。然而,发现了两种不同的标记模式,分别对应酶原状态和活化状态。